XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 9 $ 1,411,286 $ 4,259 $ (929,318) $ 486,236
Balance (in shares) at Dec. 31, 2020 86,223        
Issuance of common stock upon exercise of stock options   6,829     6,829
Issuance of common stock upon exercise of stock options (in shares) 782        
Issuance of common stock under employee stock purchase plan   6,085     6,085
Issuance of common stock under employee stock purchase plan (in shares) 106        
Vesting of restricted stock units (in shares) 1,387        
Stock based compensation   58,335     58,335
Unrealized gain (loss) on available-for sale securities     (1,818)   (1,818)
Cumulative-effect adjustment upon adoption of ASU 2020-06   (82,876)   6,198 (76,678)
Net loss       (179,879) (179,879)
Balance at Jun. 30, 2021 $ 9 1,399,659 2,441 (1,102,999) 299,110
Balance (in shares) at Jun. 30, 2021 88,498        
Balance at Mar. 31, 2021 $ 9 1,356,212 3,197 (986,973) 372,445
Balance (in shares) at Mar. 31, 2021 87,430        
Issuance of common stock upon exercise of stock options   2,259     2,259
Issuance of common stock upon exercise of stock options (in shares) 207        
Issuance of common stock under employee stock purchase plan   6,085     6,085
Issuance of common stock under employee stock purchase plan (in shares) 106        
Vesting of restricted stock units (in shares) 755        
Stock based compensation   35,103     35,103
Unrealized gain (loss) on available-for sale securities     (756)   (756)
Net loss       (116,026) (116,026)
Balance at Jun. 30, 2021 $ 9 1,399,659 2,441 (1,102,999) 299,110
Balance (in shares) at Jun. 30, 2021 88,498        
Balance at Dec. 31, 2021 $ 10 2,050,417 (2,287) (1,394,836) $ 653,304
Balance (in shares) at Dec. 31, 2021 95,140       95,140
Issuance of common stock upon exercise of stock options   4,578     $ 4,578
Issuance of common stock upon exercise of stock options (in shares) 701        
Issuance of common stock under employee stock purchase plan   8,496     8,496
Issuance of common stock under employee stock purchase plan (in shares) 285        
Vesting of restricted stock units (in shares) 777        
Stock based compensation   76,060     76,060
Unrealized gain (loss) on available-for sale securities     (14,110)   (14,110)
Net loss       (283,746) (283,746)
Balance at Jun. 30, 2022 $ 10 2,139,551 (16,397) (1,678,582) $ 444,582
Balance (in shares) at Jun. 30, 2022 96,903       96,903
Balance at Mar. 31, 2022 $ 10 2,089,660 (13,904) (1,533,431) $ 542,335
Balance (in shares) at Mar. 31, 2022 96,259        
Issuance of common stock upon exercise of stock options   422     422
Issuance of common stock upon exercise of stock options (in shares) 70        
Issuance of common stock under employee stock purchase plan   8,496     8,496
Issuance of common stock under employee stock purchase plan (in shares) 285        
Vesting of restricted stock units (in shares) 289        
Stock based compensation   40,973     40,973
Unrealized gain (loss) on available-for sale securities     (2,493)   (2,493)
Net loss       (145,151) (145,151)
Balance at Jun. 30, 2022 $ 10 $ 2,139,551 $ (16,397) $ (1,678,582) $ 444,582
Balance (in shares) at Jun. 30, 2022 96,903       96,903